Content area

|
|

Nu kommer den første vaccine mod humant papillomvirus

Forfatter(e)
Professor Susanne Krüger Kjær, professor Frede Olesen, lægechef Kim Toftager-Larsen, overlæge Carsten Sand, reservelæge Gitte I. Strauss, afdelingslæge Thomas U. Hoffmann & centerdirektør, professor Bent S. Ottesen* H:S Rigshospitalet, Juliane Marie Centret, Kræftens Bekæmpelse, København, Aarhus Universitet, Forskningsenheden for Almen Praksis og Institut for Almen Medicin, Hillerød Sygehus, Gynækologisk-Obstetrisk Afdeling, H:S Bispebjerg Hospital, Dermatologisk Afdeling, H:S Hvidovre Hospital, Børneafdelingen
Reference: 
Ugeskr Læger 2006;168(44):3827-3828
Blad nummer: 
Sidetal: 
3827-3828
Summary The first HPV vaccine is now availiable Ugeskr Læger 2006;168(44):3827-3828 More than two thirds of carcinomas of the uterine cervix are caused by human papilloma virus (HPV) types 16 and 18, and 90% of all genital warts are caused by HPV 6 and 11. In June 2006, the US Food and Drug Administration accepted the first prophylactic HPV vaccine against HPV 6, 11, 16 and 18 to be offered to girls and young women. This new vaccine is also now available in Denmark. Questions concerning economics, ethics, organization, and vaccine monitoring need to be discussed in connection with the establishment of a vaccine program. In addition, information to the general population as well as to health care providers and decision- makers should have be given a high priority.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Pedram Kazemi-Esfarjani | 18/01
2 kommentarer
af Johan Ludvig Reventlow | 18/01
1 Kommentar
af Claus Manniche | 18/01
1 Kommentar
af Bjarne Skjødt Hjaltalin | 18/01
1 Kommentar
af Yngve Lund | 17/01
13 kommentarer
af Jens Meyer Svendsen | 16/01
1 Kommentar
af Claus Rasmussen | 16/01
3 kommentarer
af Thomas Eric Olesen | 15/01
2 kommentarer